Sarasini Antonella, Arossa Alessia, Zavattoni Maurizio, Fornara Chiara, Lilleri Daniele, Spinillo Arsenio, Baldanti Fausto, Furione Milena
Virologia Molecolare, Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Ostetricia e Ginecologia, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Diagnostics (Basel). 2021 Feb 26;11(3):396. doi: 10.3390/diagnostics11030396.
Primary infection occurs when seronegative women are infected by human cytomegalovirus (HCMV). Diagnosis of primary infection is based on the following: antibody seroconversion, presence of IgM and low IgG avidity index (AI), and presence of DNAemia. The kinetics of HCMV-specific IgM antibody and maturation of AI might be very rapid or long-lasting during primary infection, which makes serological diagnosis insidious. The aims of this study were as follows: (i) to report atypical kinetics of HCMV-specific IgM antibody and AI early after onset of primary HCMV infection in a population of pregnant women, and (ii) to assess the frequency of such results. Altogether, 1309 sequential serum samples collected from 465 pregnant women with primary HCMV infection were included in the study. As a general rule, using the LIAISONCMVIgMII and LIAISONCMVIgGAvidityII assays, virus-specific IgM antibody levels decreased, while IgG AI increased over time during the first three months after infection onset. However, early clearance of IgM antibody and/or early IgG AI maturation occurred in 46/426 (10.7%) women. In more details, 20/426 (4.7%) and 26/418 (6.2%) women had undetectable IgM antibody or high IgG AI, respectively, when tested within 1-3 months after well-defined infection onset. Twenty sera from as many women with high IgG AI by the LIAISON assay were further tested for IgG AI by VIDASCMVIgGAvidityII and Mikrogen LineCMVIgG Avidity assays. Comparable results were obtained with VIDAS, whereas 14/20 sera gave low AI with the Mikrogen assay. In conclusion, about 11% of pregnant women undergoing a primary HCMV infection showed misleading serological results. Additional and appropriate testing might help in reducing the risk of missing HCMV primary infection in pregnancy. Furthermore, preconceptional testing should be strongly recommended.
原发性感染发生在血清学阴性的女性感染人巨细胞病毒(HCMV)时。原发性感染的诊断基于以下几点:抗体血清学转换、IgM的存在以及低IgG亲和力指数(AI),还有病毒血症的存在。在原发性感染期间,HCMV特异性IgM抗体的动力学和AI的成熟可能非常迅速或持续很长时间,这使得血清学诊断具有隐匿性。本研究的目的如下:(i)报告孕妇群体中原发性HCMV感染发病后早期HCMV特异性IgM抗体和AI的非典型动力学,以及(ii)评估此类结果的频率。本研究共纳入了从465例原发性HCMV感染的孕妇中采集的1309份连续血清样本。一般来说,使用LIAISON CMV IgM II和LIAISON CMV IgG Avidity II检测方法,在感染发病后的前三个月内,病毒特异性IgM抗体水平会下降,而IgG AI会随着时间增加。然而,46/426(10.7%)的女性出现了IgM抗体的早期清除和/或IgG AI的早期成熟。更详细地说,在明确感染发病后的1 - 3个月内进行检测时,分别有20/426(4.7%)和26/418(6.2%)的女性IgM抗体检测不到或IgG AI较高。对通过LIAISON检测IgG AI较高的20名女性的血清,进一步用VIDAS CMV IgG Avidity II和Mikrogen Line CMV IgG Avidity检测方法检测IgG AI。VIDAS检测得到了类似的结果,而Mikrogen检测方法对14/20的血清给出了低AI结果。总之,约11%的原发性HCMV感染孕妇呈现出误导性的血清学结果。额外且合适的检测可能有助于降低孕期漏诊HCMV原发性感染的风险。此外,强烈建议进行孕前检测。